date:May 11, 2012
pplement
But even if firmscanprove that DMAAisin geranium, and that the DMAA in their products is a synthetically produced copy of a botanical constituent, itstillshouldn't be allowed insupplements, argues Cohen.
If you can find something in one varietal of a plant in microscopic amounts, then produce it[synthetically]at pharmaceutical levels, you're producing a medication not a supplement.
In my mind, this DMAA adventure is a perfect example of a gaping loophole in DSHEA which needs to close